Clinical Trial Update: A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy [Phase 2]

View source ↗

Summary

Phase II trial evaluating loncastuximab tesirine as a consolidation therapy for patients with large B-cell lymphoma who achieved partial response after CAR-T th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma
• Lymphoma

Drugs mentioned

• Loncastuximab tesirine (loncastuximab tesirine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Large B-cell Lymphoma, Lymphoma | Phase 2 | Status: RECRUITING